Malik Kemal has filed 6 insider transactions across 1 company since July 2024.
Most recent transaction: a grant/award of 2600 shares of Cartesian Therapeutics, Inc. ($RNAC) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Malik Kemal | Director | A | Common Stock | 2600 | $0.00 | 11,133.0000 | 26,003,606 | 30.47% | 0.01% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Malik Kemal | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Malik Kemal | Director | A | Common Stock | 2600 | $0.00 | 8,533.0000 | 25,767,369 | 43.82% | 0.01% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Malik Kemal | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 25,767,369 | 9999.99% | 0.03% |
| July 1, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Malik Kemal | Director | A | Common Stock | 5933 | $0.00 | 5,933.0000 | 17,816,238 | 9999.99% | 0.03% |
| July 1, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Malik Kemal | Director | A | Stock Option (Right to Buy) | 7600 | $0.00 | 7,600.0000 | 17,816,238 | 9999.99% | 0.04% |